Christopher C.
Burris
(Chris)

Represented a major international financial institution in the internal investigation and self-disclosure of accusations of employee participation in an alleged Ponzi scheme.

Represented a large publicly traded manufacturing company in the internal investigation and self-disclosure of potential Bank Secrecy Act violations.

Represented an elected state official during a federal investigation of public corruption, which led to no charges being filed.

Represented an owner of a large privately held manufacturing company in the defense of a federal criminal tax investigation.

Represented an owner of a privately held national pharmaceutical distributor in Section 2255 proceedings regarding his conviction on mail/wire fraud and RICO charges stemming from allegations of grey market recycling of drugs.

Represented numerous national retail and specialty pharmacy chains in multiple False Claims Act /qui tam matters focusing on a variety of issues, including allegations of the payment of kickbacks, improper submission of dosage quantities, the failure to timely refund credit balances, coordination of benefits issues, the submission of incorrect “usual and customary” prices to government payors and the dispensing of expired drugs.

Represented a major national financial institution in False Claims Act /qui tam litigation involving allegations of charging borrowers unallowable fees under the Veteran Administration's Home Loan Guaranty Program.

Represented a major national skilled nursing facility chain in False Claims Act /qui tam litigation focusing on quality of care issues.

Conducted independent internal investigations on various issues, including allegations of improper accounting, theft of corporate resources, backdated stock option, FCPA violations, and misconduct in the execution of government contracts and grant programs.

Conducted an internal review for an international nongovernmental organization regarding potential FCPA issues related to an ongoing cooperative project with a foreign government.

Represented a large publicly traded corporation in one of the first national investigations by a multi-state attorneys' general task force focusing on the loss of consumer information held by the company.

Represented a Fortune 500 financial services company in a data breach response and in ensuing investigations by the Financial Industry Regulatory Authority (FINRA) and the Securities and Exchange Commission (SEC), which focused on Regulation S-P’s requirement to safeguard consumer financial and personal information.

Represented a Fortune 100 healthcare company in responding to a data security incident — and an ensuing DHHS OCR investigation — involving the theft of customers’ personal and medical information. The internal investigation that was conducted led to DHHS OCR and customer disclosures pursuant to the requirements of HIPAA and various state data breach disclosure statutes.

Represented a major international telecommunications company in its response to the disclosure of the United States' Terrorist Surveillance Program (TSP), and issues and litigation arising from the company’s alleged cooperation with the TSP.